Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct355 - viral infectious disease ivds - ivds that are intended to be used in testing to provide information about infection with or exposure to one or a number of viral diseases.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct915 - cd cell marker (cluster of differentiation) ivds - ivds that are intended to be used in histology and cytology to provide information about the presence and localisation of cell markers, collectively referred to as cd markers (cluster of differentiation) present on the surface of leukocytes.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct915 - cd cell marker (cluster of differentiation) ivds - intended to be used in combination with other ivds to perform various flow cytometry related tests and procedures.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct833 - clinical chemistry substrate ivds - ivds that are intended to be used for the qualitative and/or quantitative determination of clinical chemistry substrates in a clinical specimen.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct945 - general laboratoryware ivds - laboratoryware such as general reagents, laboratory products, consumables, biological stains, antimicrobial identification tests and antimicrobial susceptibility tests that are intended to be used specifically as an ivd in the testing of clinical specimens within any discipline of a pathology laboratory.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct1261 - microbial-isolate identification and testing ivds - ivds that are intended to be used in testing to provide information about the specific in vitro characteristics and/or identification of microorganisms including bacteria, yeast, fungi, viruses and parasites that have been isolated from a clinical specimen.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct1260 - antimicrobial susceptibility testing ivds - ivds that are intended to be used in testing to determine the antimicrobial susceptibility profile of microorganisms such as bacteria, yeast or fungi against a range of individual antimicrobial agents.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct922 - microbiological culture media ivds - ivds that are intended to be used as culture media for the selection, growth, isolation and/or differentiation of tissue cells or microorganisms including bacteria, yeast, fungi and/or viruses from a clinical specimen.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - paramagnetic particle, chemiluminescent immunoassay for qualitative detection of surface antigen hepatitis b virus hbs ag the access hbs ag assay is a paramagnetic particle, chemiluminescent immunoassay for the qualitative detection of the surface antigen of the hepatitis b virus (hbs ag) in human serum and plasma using the access immunoassay systems.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - 48316 - hepatitis b virus surface total antibody ivd, kit, chemiluminescent immunoassay - paramagnetic particle, chemiluminescent immunoassay for quantitative determination of antibody levels hep b surface antigen the access hbs ab assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of antibody levels to hepatitis b surface antigen in human serum and plasma using the access immunoassay systems.